The Department for Health and Social Care has asked NICE to conduct an appraisal of roxadustat for treating anaemia in people with chronic kidney disease.
Please note that following on from a request received from the company to reschedule the initial date proposed by NICE, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in mid-Apr 2021 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately late June 2021.